According to data provided by Zacks Research, AT&T Inc. (NYSE:T) has a consensus target price of $42.841 on the stock. Out of the polled analysts providing targets, the high is currently $48, while the low is resting at $40. Analyst price targets may vary depending on the individual method used to calculate the estimate.
Turning to earnings, analysts are expecting AT&T Inc. (NYSE:T) to post a current quarter EPS of $0.74. This consensus number is compiled by Zacks Research. For the period ending on 2017-03-31, the company reported EPS for the quarter of $0.74. The resulting surprise factor from the difference between the reported number and the consensus estimate going into earnings was 0%. After a company reports earnings, the stock may see increased activity. The next earnings report date is scheduled on or near 2017-07-20.
In terms of analyst ratings, AT&T Inc. (NYSE:T) has a current ABR of 2.45. This average broker recommendation is given by Zacks using a scale from 1 to 5. According to this scale, a rating of 1 or 2 would indicate a Buy, and a rating of 4 or 5 would signify a Sell recommendation. A 3 would indicate a Hold on the stock.
Research analysts covering Kura Oncology Inc (NASDAQ:KURA) are projecting that the shares reach $15.5 within the next 12-18 months. This is the consensus number derived from the 2 analyst reports taken into consideration. The most bullish, or aggressive analyst target pins the projected price at $16, while the most bearish, or conservative analyst sees the stock reaching $15.
Broker Rating Update on Kura Oncology Inc (NASDAQ:KURA)
Zacks provides analysts with an Average Broker Rating (or ABR), basing it on sell-side recommendations. Shares of Kura Oncology Inc (NASDAQ:KURA) currently have an ABR of 1. This is based on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Moving to earnings estimates, for this current fiscal period, Wall Street analysts have projected that the company will post $-0.46 earnings per share. This is the current Zacks consensus EPS which was calculated at the time of writing. Analysts will likely revise their estimates leading in to the actual results date.
taking a look at the most recent period, which closed on 2016-12-31, Kura Oncology Inc reported EPS of $-0.38 for a surprise factor of 2.56%, calculated by being $0.01 away from analyst projections.
Investors will be marking their calendars for 2017-05-10, when the company is planning to release their quarterly results.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.